Evaluation of longevity enhancing compounds against transactive response DNA-binding protein-43 neuronal toxicity

Arnaud Tauffenberger1, Carl Julien, J Alex Parker

  • 1CRCHUM, Montréal, Québec, Canada.

Neurobiology of Aging
|April 18, 2013
PubMed

Insights

Lifespan-extending compounds in C. elegans do not always protect against neurodegeneration. Some, like resveratrol and ethosuximide, show neuroprotective effects, with specific genetic dependencies.

Area of Science:

  • Neuroscience
  • Aging Research
  • Genetics

Background:

  • Lifespan extension in simple organisms involves pathways like dietary restriction and insulin/IGF signaling.
  • Mechanisms promoting longevity are often presumed to mitigate age-related diseases.
  • Neurodegenerative diseases, such as those linked to TAR DNA-binding protein-43 (TDP-43), represent significant age-associated pathologies.

Purpose of the Study:

  • To investigate if compounds known to extend lifespan in C. elegans can protect against TDP-43-induced motor neuron toxicity.
  • To determine the predictive value of lifespan extension for neuroprotective properties.

Main Methods:

  • Utilized C. elegans as a model system to study neurodegeneration.
  • Administered compounds previously reported to extend lifespan to assess their efficacy against TDP-43 toxicity.
  • Analyzed neuroprotection and identified genetic dependencies (daf-16, sir-2.1) for specific compounds.

Main Results:

  • Only half of the tested lifespan-extending compounds demonstrated neuroprotective effects against TDP-43 toxicity.
  • Resveratrol, rolipram, reserpine, trolox, propyl gallate, and ethosuximide were identified as protective agents.
  • Resveratrol's protection was dependent on daf-16 and sir-2.1, while ethosuximide's required daf-16.

Conclusions:

  • Extended lifespan is not a reliable predictor of neuroprotective capacity against TDP-43-induced toxicity.
  • Specific compounds exhibit neuroprotection, highlighting distinct mechanisms beyond general lifespan extension.
  • The genetic pathways daf-16 and sir-2.1 play roles in mediating the neuroprotective effects of certain compounds.